An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis - Atlantic Healthcare

HEALTHCARE PRACTITIONERS
CONTACT US

About
Research
Therapeutic Focus
- Crohn’s Disease
- Ulcerative colitis
Pipeline
Investors
News
- Conferences

Search

HEALTHCARE PRACTITIONERS
CONTACT US

P. Miner JR, M. Wedel, B. Bane & J. Bradley

Aliment Pharmacol Ther (2004) 19: 281-286

Recent Posts

Atlantic Healthcare to attend WuXi Global Forum, January 11-13th 2021
8th January 2021
Atlantic Healthcare invited to attend the JP Morgan Healthcare Conference 2021
8th January 2021
Featured in Nature magazine…. A lower risk, higher value, late stage pipeline for gastrointestinal diseases
1st December 2020
Atlantic Healthcare plc appoints pharmaceutical industry veteran Allan Cambridge to the Board of Directors
19th November 2020
Atlantic Healthcare appoints Chief Medical Officer (CMO) and Head of Clinical Development
9th October 2020

Follow

Privacy Preference Center

Privacy Preferences